MedTrace Logo

Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery

NCT03482973 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-08-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether administration of a pecto-intercostal fascial plane block (PIFB) with bupivacaine is a more effective therapy for postoperative analgesia after cardiac surgery as compared to patients who receive a sham block of normal saline.

Conditions

Interventions

DRUG

Bupivacaine Group

20cc bupivacaine hydrochloride will be administered on each side at two different time points (immediately post operatively and on day 1).

OTHER

Placebo

20cc placebo (0.9% NaCl) will be administered on each side at two different time points (immediately post operatively and on day 1).

Sponsors & Collaborators

Principal Investigators

  • Balachundhar Subramaniam · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-21
Primary Completion
2019-11-25
Completion
2019-11-27
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482973 on ClinicalTrials.gov